9885 Stock Overview
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 9885 from our risk checks.
YSB Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$8.04 |
| 52 Week High | HK$64.50 |
| 52 Week Low | HK$5.91 |
| Beta | 0 |
| 1 Month Change | -0.99% |
| 3 Month Change | 15.35% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -61.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9885 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 2.8% | 7.9% | 5.2% |
| 1Y | n/a | -28.4% | -9.1% |
Return vs Industry: Insufficient data to determine how 9885 performed against the Hong Kong Healthcare industry.
Return vs Market: Insufficient data to determine how 9885 performed against the Hong Kong Market.
Price Volatility
| 9885 volatility | |
|---|---|
| 9885 Average Weekly Movement | 9.7% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.8% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 9885's share price has been volatile over the past 3 months.
Volatility Over Time: 9885's weekly volatility has decreased from 17% to 10% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 6,306 | Buzhen Zhang | www.ysbang.cn |
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. It also engages in the wholesale and retail of pharmaceutical and healthcare products.
YSB Inc. Fundamentals Summary
| 9885 fundamental statistics | |
|---|---|
| Market cap | HK$5.15b |
| Earnings (TTM) | -HK$3.45b |
| Revenue (TTM) | HK$18.33b |
0.3x
P/S Ratio-1.5x
P/E RatioIs 9885 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9885 income statement (TTM) | |
|---|---|
| Revenue | CN¥16.97b |
| Cost of Revenue | CN¥15.23b |
| Gross Profit | CN¥1.74b |
| Other Expenses | CN¥4.93b |
| Earnings | -CN¥3.19b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.98 |
| Gross Margin | 10.26% |
| Net Profit Margin | -18.79% |
| Debt/Equity Ratio | 3.1% |
How did 9885 perform over the long term?
See historical performance and comparison